Drugs / RP-008
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07596485 | Aug 2026 → Feb 2029 expected | trigeminal neuralgia | Kriya Therapeutics, Inc. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RP-008 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07596485 ↗ |
| Known as | KRIYA-748 | “KRIYA-748” NCT07596485 ↗ |
| Route | Other | “single percutaneous injection” NCT07596485 ↗ |